MedTrace Logo

Effectiveness of a Multifactorial Intervention in Frailty Individuals With HIV Infection: HIDRA360

NCT05832164 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2023-09-06

No results posted yet for this study

Summary

The goal of this quasi-experimental before/after study without equivalent control group is to to describe the prevalence of frail, pre-fragile and robust individuals in the study group before and after a multifactorial intervention in in frail HIV patients.

The main questions it aims to answer are after a multifactorial intervention:

1. To describe the sociodemographic, viroimmunological and ART exposure factors of fragile individuals compared to pre-fragile and robust individuals.
2. To describe adherence to the Mediterranean diet in frail individuals compared to pre-frail and robust individuals.
3. To describe the presence of anxiety and depression in frail individuals with respect to pre-fragile and robust individuals.
4. To describe the analytical parameters and inflammatory markers of frail individuals with respect to pre-fragile and robust individuals.
5. To describe the diversity and composition of the intestinal microbiota of frail individuals with respect to pre-fragile and robust individuals.
6. To describe the body composition of frail individuals with respect to pre-fragile and robust individuals.
7. To describe the factors associated with progression to frailty or robustness after six months of a multifactorial intervention.

Conditions

  • Frailty Syndrome
  • HIV Infections

Interventions

OTHER

Multifactorial intervention

* Adherence to a Mediterranean diet. * Progressive aerobic and anaerobic exercise program. * Review of polypharmacy * Group socialization activities

Sponsors & Collaborators

  • Hospital Costa del Sol

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-15
Primary Completion
2023-10-31
Completion
2024-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05832164 on ClinicalTrials.gov